CVS Health (CVS) Suffers a Larger Drop Than the General Market: Key Insights

CVS Health closed down 1.17%, underperforming the S&P 500's 0.45% decline. Despite beating the Medical sector over the past month with a 1.64% gain, the company faces flat EPS projections for the upcoming quarter at $1.6, though full-year earnings are expected to grow 18.81%. CVS trades at a Forward P/E of 11.91, below its industry average, and holds a Zacks Rank #3 (Hold) rating.